Related Experiment Videos
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes
J Fareed1, D A Hoppensteadt, F Leya
1Loyola University Medical Center, Department of Pathology, Maywood, IL 60153, USA. jfareed@wpo.it.luc.edu
Insights
This review covers laboratory tests for thrombogenesis in acute coronary syndromes, aiding research into disease mechanisms. Further studies are needed to confirm their clinical utility and cost-effectiveness for diagnosis and management.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Biochemistry
Background:
- Acute coronary syndromes (ACS) involve complex thrombogenesis.
- Understanding the pathophysiology of ACS is crucial for effective treatment.
- Laboratory tests offer insights into the coagulation cascade and inflammatory processes in ACS.
Purpose of the Study:
- To review laboratory tests evaluating thrombogenesis in ACS.
- To highlight the value of these tests as research tools.
- To assess their potential for clinical diagnosis and management.
Main Methods:
- Comprehensive literature review of laboratory tests related to thrombogenesis in ACS.
- Categorization and description of various biomarkers including coagulation factors, inhibitors, fibrinolytic markers, platelet activation markers, and inflammatory mediators.
- Discussion of the role of each test in understanding ACS pathophysiology.
Main Results:
- Numerous laboratory tests, including tissue factor, prothrombin fragment 1.2, D-dimer, and various inflammatory markers, are valuable research tools for ACS.
- These tests provide detailed insights into the complex thrombotic and inflammatory pathways involved in ACS.
- Specific markers like tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) are discussed in detail.
Conclusions:
- Laboratory tests are instrumental in advancing the understanding of ACS pathophysiology.
- Some evaluated tests show promise for clinical application in ACS diagnosis and management.
- Clinical outcome studies are essential to validate the cost-effectiveness and medical utility of these diagnostic tests.
Abstract:
We review laboratory tests that evaluate thrombogenesis during acute coronary syndromes. These tests have been found to be valuable research tools in more clearly understanding the pathophysiology of acute coronary syndromes. In particular, we describe tissue factor, tissue factor pathway inhibitor, prothrombin fragment 1.2, thrombin-antithrombin complex, fibrinopeptide A, tissue plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1), t-PA-PAI complex, Bbeta 15-42-related peptides, fibrinogen degradation products, fibrin degradation products, D-dimer, platelet factor 4, beta-thromboglobulin, 5-hydroxytryptamine, thromboxane B2, prostacyclin, endothelin, angiotensin-converting enzyme, soluble thrombomodulin, C1-esterase inhibitor, anaphylotoxins C3a, C4a, and C5a, bradykinin, tumor necrosis factor, leukotriene C4, platelet activating factor, anti-phospholipid antibody, and von Willebrand factor. Some of these tests may prove to be useful in clinical diagnosis and management of acute coronary syndromes. Clinical outcome studies are needed to determine which tests may be cost effective and medically useful.